Logo image of STKE

SOL STRATEGIES INC (STKE) Stock Fundamental Analysis

USA - NASDAQ:STKE - CA83411A2056 - Common Stock

3.09 USD
-0.12 (-3.74%)
Last: 10/17/2025, 8:00:00 PM
4.16 USD
+1.07 (+34.63%)
After Hours: 10/17/2025, 8:00:00 PM
Fundamental Rating

2

STKE gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 239 industry peers in the Capital Markets industry. STKE may be in some trouble as it scores bad on both profitability and health. STKE is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

STKE had negative earnings in the past year.
STKE had a negative operating cash flow in the past year.
In multiple years STKE reported negative net income over the last 5 years.
In the past 5 years STKE reported 4 times negative operating cash flow.
STKE Yearly Net Income VS EBIT VS OCF VS FCFSTKE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M 80M

1.2 Ratios

STKE's Return On Assets of -2.64% is on the low side compared to the rest of the industry. STKE is outperformed by 79.08% of its industry peers.
STKE has a Return On Equity of -4.25%. This is in the lower half of the industry: STKE underperforms 77.41% of its industry peers.
STKE has a worse Return On Invested Capital (0.57%) than 71.13% of its industry peers.
Industry RankSector Rank
ROA -2.64%
ROE -4.25%
ROIC 0.57%
ROA(3y)-4.16%
ROA(5y)-3.71%
ROE(3y)-3.7%
ROE(5y)-3.54%
ROIC(3y)N/A
ROIC(5y)N/A
STKE Yearly ROA, ROE, ROICSTKE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100 -150

1.3 Margins

The Operating Margin of STKE (5.82%) is worse than 69.46% of its industry peers.
The Profit Margin and Gross Margin are not available for STKE so they could not be analyzed.
Industry RankSector Rank
OM 5.82%
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
STKE Yearly Profit, Operating, Gross MarginsSTKE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50K -50K 100K

More info and screens

2

2. Health

2.1 Basic Checks

STKE has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, STKE has more shares outstanding
There is no outstanding debt for STKE. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
STKE Yearly Shares OutstandingSTKE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
STKE Yearly Total Debt VS Total AssetsSTKE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

2.2 Solvency

STKE has an Altman-Z score of 0.96. This is a bad value and indicates that STKE is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of STKE (0.96) is comparable to the rest of the industry.
STKE has a Debt/Equity ratio of 0.54. This is a neutral value indicating STKE is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.54, STKE is in the better half of the industry, outperforming 63.18% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.54
Debt/FCF N/A
Altman-Z 0.96
ROIC/WACCN/A
WACCN/A
STKE Yearly LT Debt VS Equity VS FCFSTKE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M 80M

2.3 Liquidity

A Current Ratio of 0.17 indicates that STKE may have some problems paying its short term obligations.
The Current ratio of STKE (0.17) is worse than 90.79% of its industry peers.
STKE has a Quick Ratio of 0.17. This is a bad value and indicates that STKE is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of STKE (0.17) is worse than 90.79% of its industry peers.
Industry RankSector Rank
Current Ratio 0.17
Quick Ratio 0.17
STKE Yearly Current Assets VS Current LiabilitesSTKE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

More info and screens

6

3. Growth

3.1 Past

The earnings per share for STKE have decreased strongly by -465.40% in the last year.
Looking at the last year, STKE shows a very strong growth in Revenue. The Revenue has grown by 787.33%.
STKE shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 196.62% yearly.
EPS 1Y (TTM)-465.4%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-468.86%
Revenue 1Y (TTM)787.33%
Revenue growth 3Y196.62%
Revenue growth 5YN/A
Sales Q2Q%324.76%

3.2 Future

STKE is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -116.96% yearly.
Based on estimates for the next years, STKE will show a very strong growth in Revenue. The Revenue will grow by 67.47% on average per year.
EPS Next Y-382.82%
EPS Next 2Y-116.96%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year100.9%
Revenue Next 2Y67.47%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
STKE Yearly Revenue VS EstimatesSTKE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2020 2021 2022 2023 2024 2025 2026 0 5M -5M 10M 15M 20M
STKE Yearly EPS VS EstimatesSTKE Yearly EPS VS EstimatesYearly EPS VS Estimates 2025 2026 -0.2 -0.4 -0.6

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for STKE. In the last year negative earnings were reported.
Also next year STKE is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
STKE Price Earnings VS Forward Price EarningsSTKE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40

4.2 Price Multiples

STKE's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. STKE is cheaper than 73.64% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 19.39
STKE Per share dataSTKE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2

4.3 Compensation for Growth

A cheap valuation may be justified as STKE's earnings are expected to decrease with -116.96% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-116.96%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for STKE!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SOL STRATEGIES INC

NASDAQ:STKE (10/17/2025, 8:00:00 PM)

After market: 4.16 +1.07 (+34.63%)

3.09

-0.12 (-3.74%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)08-26 2025-08-26
Earnings (Next)01-26 2026-01-26
Inst Owners0.67%
Inst Owner ChangeN/A
Ins Owners17.11%
Ins Owner ChangeN/A
Market Cap81.70M
Analysts82.86
Price Target21.05 (581.23%)
Short Float %6.67%
Short Ratio1.08
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-2.12%
PT rev (3m)N/A
EPS NQ rev (1m)0%
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 5.86
P/FCF N/A
P/OCF N/A
P/B 1.12
P/tB 3.57
EV/EBITDA 19.39
EPS(TTM)-0.13
EYN/A
EPS(NY)-0.49
Fwd EYN/A
FCF(TTM)-0.44
FCFYN/A
OCF(TTM)-0.23
OCFYN/A
SpS0.53
BVpS2.75
TBVpS0.87
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -2.64%
ROE -4.25%
ROCE 0.79%
ROIC 0.57%
ROICexc 0.58%
ROICexgc 1.05%
OM 5.82%
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-4.16%
ROA(5y)-3.71%
ROE(3y)-3.7%
ROE(5y)-3.54%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score1
Asset Turnover0.12
Health
Industry RankSector Rank
Debt/Equity 0.54
Debt/FCF N/A
Debt/EBITDA 7.08
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.17
Quick Ratio 0.17
Altman-Z 0.96
F-Score1
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-465.4%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-468.86%
EPS Next Y-382.82%
EPS Next 2Y-116.96%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)787.33%
Revenue growth 3Y196.62%
Revenue growth 5YN/A
Sales Q2Q%324.76%
Revenue Next Year100.9%
Revenue Next 2Y67.47%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y14.8%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-1629.57%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-818.64%
OCF growth 3YN/A
OCF growth 5YN/A